Finance

Lists
THC:NYSE
Tenet Healthcare Corp
272,32 USD
+0,09%
(+0,24) 1D
20-окт., 16:00:03 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for THC...
Mkt. cap
21,93 млд
Avg. vol.
681,42 миң
Volume
0,00
P/E ratio
10,50
52-wk high
283,05 USD
52-wk low
157,58 USD
EPS
25,93 USD
Beta
1,20
Shares outstanding
80,52 млн
No. of employees
88 миң
Mkt. cap
21,93 млд
Avg. vol.
681,42 миң
Volume
0,00
P/E ratio
10,50
52-wk high
283,05 USD
52-wk low
157,58 USD
EPS
25,93 USD
Beta
1,20
Shares outstanding
80,52 млн
No. of employees
88 миң
News stories
From web sources and news partners
Profile
Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International, the company operates around 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients. Since its founding in 1969, Tenet has expanded significantly. Among other major acquisitions and formations, Tenet founded Conifer Health Solutions in 2008, MedPost Urgent Care in 2014, and in 2013 acquired Vanguard Health Systems, Inc., an investor-owned hospital company whose operations complemented Tenet's existing business. The acquisition created the third-largest investor-owned hospital company in the United States in terms of revenue and the third-largest in number of hospitals owned. In 2015, Tenet acquired USPI, which created the largest operator of outpatient surgery centers in the U.S. In 2021, the company ranked 167th in the Fortune 500. Wikipedia
About Tenet Healthcare Corp
CEOSaum Sutaria
Employees88,5 миң
Founded1969
HeadquartersДаллас, Техас, Америка Кошмо Штаттары
SectorHealth care provider
Analyst ratings
Based on 18 analysts giving stock ratings to THC in the past 3 months
Strong buy
Buy
16
Hold
2
Sell
0
12-month forecast
Based on 18 Wall Street analysts offering 12 month price targets for THC in the last 3 months.
Highest
Current 272,32 USD
315,00 USD (+15,67%)
Average
284,82 USD (+4,59%)
Lowest
245,00 USD (-10,03%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason Cassorla
Guggenheim
Buy
Reiterated
307,00 USD
+12,7%
10/16/2026
Craig Hettenbach
Morgan Stanley
Buy
Reiterated
274,00 USD
+0,6%
10/12/2026
Ben Hendrix
RBC Capital
Buy
Maintained
283,00 USD
+3,9%
10/07/2026
Andrew Cooper
Raymond James
Buy
Reiterated
285,00 USD
+4,7%
09/28/2026
Sean Dodge
BMO Capital
Hold
Initiated
265,00 USD
-2,7%
09/22/2026
Whit Mayo
Leerink Partners
Buy
Reiterated
-
-
09/17/2026
Benjamin Rossi
J.P. Morgan
Buy
Maintained
315,00 USD
+15,7%
09/01/2026
A.J. Rice
UBS
Buy
Maintained
308,00 USD
+13,1%
08/25/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
290,00 USD
+6,5%
08/10/2026
Kevin Fischbeck
Bank of America Securities
Buy
Reiterated
295,00 USD
+8,3%
08/10/2026
Stephen Baxter
Wells Fargo
Buy
Reiterated
281,00 USD
+3,2%
07/31/2026
Scott Fidel
Goldman Sachs
Buy
Reiterated
305,00 USD
+12%
07/29/2026
Michael Ha
Robert W. Baird
Hold
Maintained
280,00 USD
+2,8%
07/28/2026
Unknown Analyst
Stephens
Buy
Maintained
285,00 USD
+4,7%
07/27/2026
Raj Kumar CFA
Stephens
Buy
Maintained
285,00 USD
+4,7%
07/27/2026
David S Macdonald
Truist Financial
Buy
Reiterated
290,00 USD
+6,5%
07/28/2026
Ryan Langston
TD Cowen
Buy
Reiterated
263,00 USD
-3,4%
07/27/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
245,00 USD
-10%
07/23/2026
Andrew Mok CFA
Barclays
Buy
Maintained
271,00 USD
-0,5%
07/24/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
225,00 USD
-17,4%
05/01/2026
Next call 8 күндөн кийин
29-окт., бейш., 16:00
Fiscal period
Q3 2026
- / 4,67 USD
Revenue / Est. (USD)
- / 5,51 млд
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
5,29 млд
5,53 млд
5,37 млд
5,63 млд
Cost of goods sold
3,14 млд
3,23 млд
3,14 млд
3,22 млд
Cost of revenue
3,14 млд
3,23 млд
3,14 млд
3,22 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
102,00 млн
410,00 млн
102,00 млн
104,00 млн
Operating expense
1,34 млд
1,33 млд
1,27 млд
1,39 млд
Total operating expenses
4,47 млд
4,56 млд
4,40 млд
4,61 млд
Operating income
815,00 млн
965,00 млн
963,00 млн
1,02 млд
Other non operating income
31,00 млн
39,00 млн
43,00 млн
45,00 млн
EBT including unusual items
712,00 млн
681,00 млн
1,13 млд
1,34 млд
EBT excluding unusual items
704,00 млн
882,00 млн
852,00 млн
928,00 млн
Income tax expense
133,00 млн
37,00 млн
226,00 млн
295,00 млн
Effective tax rate
18,68%
5,43%
19,96%
22,01%
Other operating expenses
1,02 млд
687,00 млн
937,00 млн
1,07 млд
Net income
342,00 млн
371,00 млн
702,00 млн
826,00 млн
Net profit margin
6,47%
6,71%
13,08%
14,68%
Earnings per share
3,70
4,70
4,82
6,12
Interest and investment income
-
-
-
-
Interest expense
-206,00 млн
-205,00 млн
-205,00 млн
-204,00 млн
Net interest expenses
-206,00 млн
-205,00 млн
-205,00 млн
-204,00 млн
Depreciation and amortization charges
218,00 млн
231,00 млн
229,00 млн
215,00 млн
EBITDA
1,03 млд
1,20 млд
1,19 млд
1,24 млд
Gain or loss from assets sale
-20,00 млн
5,00 млн
-1,00 млн
-33,00 млн
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору